The center for lung diseases provides comprehensive, customized non-clinical trials in lung diseases. Experts and researchers provide a complete solution to an experiment beginning from experimental design to the experimental outcome. N-CEC lung center offers a wide range of non-clinical trials, including Asthma and fibrosis models. Center's collaborations with other institutes strengthen the quality of services provided by the center. We are part of Jeonbuk National University Hospital, which provides world-class health care through excellent service, training, and research. Being a part of the nation's premier health care center for lung disease, N-CEC offers the best class facility for non-clinical trials. This fact, combined with an experienced team, means N-CEC offers the best possible services. At N-CEC, experts aren't just researchers; they are also actively involved in educating medical, Ph. D, and master students and other research communities about the latest advances in lung disease. This means services provided at N-CEC lung center are specialists who are up-to-date on the most current research and treatment options in this rapidly evolving specialty.
A network with other reputed institutes is a valuable asset and enhances the quality of the research and services.
Center has been approved by Jeonbuk National University Hospital and AAALAC. Center staffs have several years of good laboratory practice (GLP) experience.
Our center has exclusive in vitro and in vivo research facilities. These facilities are one of the finest, ell-equipped facilities in the Republic of Korea.
Our team is centers pillar for success. We are regarded as pioneers in the non-clinical evaluation in Jeonbuk National University Hospital, Jeonju. We lead our sponsor’s first step towards commercial success of their product.
Lung disease condition restricts the lungs from working efficiently. These conditions affect the amount of air we breathe in or out and also how much oxygen is going from the lungs to the rest of the body. For any potential pharmaceutical compound, lung function drives the clinical efficacy and eventual commercial applications. Non-clinical evaluation is the first important step towards the commercialization of a potential compound. Center has professionals who are well versed on the most current research and treatments in this dynamic and rapidly changing field. We have a wide range of non-clinical services for lung diseases.
If you need further information, please get in touch with us.
Keep track of our recent scientific publications. Center for lung diseases believes in integrated approach, and we have published several high-impact investigations in collaborations with our partnering institutes.
Glucose-lowering effect of Gryllus bimaculatus powder on streptozotocin-induced diabetes through the AKT/mTOR pathway
Phosphatidylinositol 3-kinase-delta controls endoplasmic reticulum membrane fluidity and permeability in fungus-induced allergic inflammation in mice
The correlation of IRE1alpha oxidation with Nox4 activation in aging-associated vascular dysfunction
Ixeris dentata and Lactobacillus gasseri Extracts Improve Salivary Secretion Capability in Diabetes-Associated Dry Mouth Rat Model
TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lysosomal calcium
Platycodi Radix and its active compounds ameliorate against house dust mite-induced allergic airway inflammation and ER stress and ROS by enhancing anti-oxidation
NCEC actively associates itself with its client's business and delivers the projects on time and within budget. NCEC's knowledge and experience in various non-clinical services expertly translate what clients want into a specific trial.
Thank you for your interest non-clinical research in lung diseases. We’d love to hear from you.
+82-632593715
+82-632593565
dosung77@jbnu.ac.kr
dosung77@ncec.co.kr
Non-Clinical Center for Lung Diseases 20 Geonji-ro, Deokjin-gu, Jeonju-si, Jeollabuk-do 54907, Republic of Korea.
